NDC 50458-577-01 - XARELTO

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50458-577
Requested NDC
50458-577-01
Package NDCs from labels
50458-577-60, 50458-577-18, 50458-577-14, 50458-577-01, 50458-577-10
Manufacturer
Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Patheon, Inc. | Bayer AG | Bayer Aktiengesellschaft | LUSOMEDICAMENTA - SOCIEDADE TÉCNICA FARMACÊUTICA, S.A. | Johnson & Johnson Private Limited | Janssen Ortho LLC | Janssen Pharmaceuticals Inc.
Effective date
2026-09-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
XARELTOJanssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Patheon, Inc. | Bayer AG | Bayer Aktiengesellschaft | LUSOMEDICAMENTA - SOCIEDADE TÉCNICA FARMACÊUTICA, S.A. | Johnson & Johnson Private Limited | Janssen Ortho LLC | Janssen Pharmaceuticals Inc.2026-09-10HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50458-577-01XARELTO10 in 1 BLISTER PACKTABLET, FILM COATED1064
50458-577-10XARELTO10 in 1 BOX, UNIT-DOSETABLET, FILM COATED1064
50458-577-14XARELTO14 in 1 BOTTLETABLET, FILM COATED1464
50458-577-18XARELTO180 in 1 BOTTLETABLET, FILM COATED18064
50458-577-60XARELTO60 in 1 BOTTLETABLET, FILM COATED6064

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50458-577XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT XARELTO (RIVAROXABAN) GRANULE, FOR SUSPENSION [JANSSEN PHARMACEUTICALS, INC.]59Current NDC, Legacy NDC, 5 package rows20250409_10db92f9-2300-4a80-836b-673e1ae91610.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50458-577-01EA - Each50458-5774441aa0e-0318-4e84-932e-0d043e49981812018-12-13
50458-577-10EA - Each50458-5771b68c21e-da18-4ee4-bdd2-f7959866cb3312018-11-06
50458-577-14EA - Each50458-5771c9515e9-13ba-4f08-9582-135b5425b6bb12022-03-09
50458-577-18EA - Each50458-57797e3c3ad-64bd-4e2d-bb78-7d68267f2f2712018-11-06
50458-577-60EA - Each50458-577426d617a-af8e-4499-9d8f-1309d1dc964812018-11-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
rivaroxabanACTIVE INGREDIENT9NDF7JZ4M3XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
rivaroxabanACTIVE MOIETY9NDF7JZ4M3XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61UXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
croscarmellose sodiumINACTIVE INGREDIENTM28OL1HH48XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
ferric oxide redINACTIVE INGREDIENT1K09F3G675XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
hypromellosesINACTIVE INGREDIENT3NXW29V3WOXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
lactose monohydrateINACTIVE INGREDIENTEWQ57Q8I5XXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
magnesium stearateINACTIVE INGREDIENT70097M6I30XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
polyvinyl alcoholINACTIVE INGREDIENT532B59J990XARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
sodium lauryl sulfateINACTIVE INGREDIENT368GB5141JXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
talcINACTIVE INGREDIENT7SEV7J4R1UXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 129 · 2,569 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17W1TITANIUM DIOXIDEAmorepacific Corporation5eb39387-7f6b-ce78-e063-6394a90a15ae2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21C2TITANIUM DIOXIDEAmorepacific Corporation5eb3c3ad-8a77-0655-e063-6394a90ae9e02026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21N1TITANIUM DIOXIDEAmorepacific Corporation5eb3ddb5-4e2b-17d4-e063-6394a90aaa552026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 22N1TITANIUM DIOXIDEAmorepacific Corporation5eb415b3-b1ba-42b8-e063-6394a90a90d72026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21W1TITANIUM DIOXIDEAmorepacific Corporation5eb42062-f298-5186-e063-6294a90ab0432026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23C2TITANIUM DIOXIDEAmorepacific Corporation5eb44e1b-b24b-6c83-e063-6394a90a4b522026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23W1TITANIUM DIOXIDEAmorepacific Corporation5eb468db-3c38-922d-e063-6294a90adef82026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24N1TITANIUM DIOXIDEAmorepacific Corporation5eb4b8ca-eced-b7ff-e063-6394a90aaefe2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24O1TITANIUM DIOXIDEAmorepacific Corporation5eb4f87a-b4dc-1aa5-e063-6294a90a2ec42026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 25W1TITANIUM DIOXIDEAmorepacific Corporation5eb50784-444e-3bf3-e063-6294a90aa6182026-10-25WarningsExact identifier
unii: 15FIX9V2JP
Clear Eyes Triple ReliefPOLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDEPrestige Brands Holdings, Inc.1269a1a6-843d-4d08-bb3c-c1f3d2e7080d2026-10-23WarningsExact identifier
unii: 532B59J990
RivaroxabanRIVAROXABANApotex Corp.e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd2026-10-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2059015
unii: 9NDF7JZ4M3
KARYNG Complete SPF Sunscreen Medium/DarkSUNSCREENKaryng LLC335eee1e-ef1c-41da-e063-6294a90ac2732026-10-20WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.